About GenomeWeb Premium

Get the full story with GenomeWeb Premium!

GenomeWeb Premium provides exclusive, in-depth coverage of the latest genomic and genetic technologies, life science research trends, and key issues in molecular diagnostics. Upgrade your account to get the best of GenomeWeb's original reporting and track the topics of most interest to you.

Premium membership gives you unrestricted access across the entire GenomeWeb site. This entitles you to any article featuring the GenomeWeb Premium icon: 

Premium access also entitles you to opt into any of our weekly topical mailings, which include:

  • Molecular Diagnostics
  • Cancer
  • Infectious Disease
  • Sequencing Technology
  • PCR
  • Informatics
  • Proteomics & Protein Research

Pricing is based on the number of users included in your GenomeWeb Premium membership.

Company-wide licenses are available for organizations of any size, from small startups to multinational organizations.

Interested? Try GenomeWeb Premium for 90 days for only $95. The trial offer is for new subscribers only and is non-refundable. 

Try GenomeWeb Premium now.

If you still have questions, please contact customerservice@genomeweb.com for further information.

Terms of Service for GenomeWeb Premium Licenses

All GenomeWeb content is protected by US and International copyright laws, and may not be copied, reprinted, published, translated, hosted, or otherwise distributed by any means without explicit permission.

Password sharing and redistribution of content are violations of the GenomeWeb Premium license agreement and are monitored. All Premium license users must log in with their own individual work email addresses. Premium users may not store premium articles on an internal or external web page accessible to other users, nor may they email full text or partial text articles to anyone inside or outside the subscribing organization without prior permission of GenomeWeb.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.